Development of an inhibitor screening platform via mass spectrometry

Journal of Biomolecular Screening

Volumn 13, Issue 10, 2008, Pages 1007-1013

  Rathore, Rakesh ^a   Corr, Jay ^b   Scott, George ^b   Vollmerhaus, Pauline ^b   Greis, Kenneth D ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b MDS Analytical Technologies   (Canada)

Author keywords

High throughput screening; Label free screening; Mass spectrometry; Matrix assisted laser desorption ionization (MALDI); Protein kinase A

Indexed keywords

ADENOSINE DIPHOSPHATE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; REAGENT;

ARTICLE; COMPARATIVE STUDY; COST; FLUORESCENCE ANALYSIS; IC 50; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEASUREMENT; PRIORITY JOURNAL; REPRODUCIBILITY; SAMPLE; SCREENING; SENSITIVITY ANALYSIS; VALIDATION STUDY; VELOCITY;

ADENOSINE DIPHOSPHATE; ENZYME INHIBITORS; FLUORESCENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 58149397935     PISSN: 10870571     EISSN: 1552454X     Source Type: Journal    
DOI: 10.1177/1087057108326143     Document Type: Article

References (15)

1. Greis KD: Mass spectrometry for enzyme assays and inhibitor screening: an emerging application in pharmaceutical research. Mass Spectrom Rev 2007 ; 26: 324-339.
2. De Boer AR, Lingeman H., Niessen WM, Irth H.: Mass spectroscopy-based biochemical assays for enzyme-inhibitor screening. Trends Anal Chem 2007 ; 26: 867-883.
3. Greis KD, Zhou S., Burt TM, Carr AN, Dolan E., Easwaran V.,, et al. MALDI-TOF MS as a label-free approach to rapid inhibitor screening. J Am Soc Mass Spectrom 2006 ; 17: 815-822.
4. Ozbal CC, LaMarr WA, Linton JR, Green DF, Katz A., Morrison TB,, et al. High throughput screening via mass spectrometry: a case study using acetylcholinesterase. Assay Drug Dev Technol 2004 ; 2: 373-381.
5. Corr JJ, Kovarik P., Schneider BB, Hendrikse J., Loboda A., Covey TR: Design considerations for high speed quantitative mass spectrometry with MALDI ionization. J Am Soc Mass Spectrom 2006 ; 17: 1129-1141.
6. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999 ; 4: 67-73.
7. Fox S., Farr-Jones S., Sopchak L., Boggs A., Nicely HW, Khoury R.,, et al. High-throughput screening: update on practices and success. J Biomol Screen 2006 ; 11: 864-869.
8. Miick SM, Jalali S., Dwyer BP, Havens J., Thomas D., Jimenez MA,, et al. Development of a microplate-based, electrophoretic fluorescent protein kinase A assay: comparison with filter-binding and fluorescence polarization assay formats. J Biomol Screen 2005 ; 10: 329-338.
9. Hopkins AL, Groom CR: The druggable genome. Nat Rev Drug Discov 2002 ; 9: 727-730.
10. Ma H., Deacon S., Horiuchi K.: The challenge of selecting protein kinase assays for lead discovery optimization. Expert Opin Drug Discov 2008 ; 3: 607-621.
11. Forbes CD, Toth JG, Ozbal CC, Lamarr WA, Pendleton JA, Rocks S.,, et al. High-throughput mass spectrometry screening for inhibitors of phosphatidylserine decarboxylase. J Biomol Screen 2007 ; 12: 628-634.
12. Hu L., Jiang G., Xu S., Pan C., Zou H.: Monitoring enzyme reaction and screening enzyme inhibitor based on MALDI-TOF-MS platform with a matrix of oxidized carbon nanotubes. J Am Soc Mass Spectrom 2006 ; 17: 1616-1619.
13. Charter NW, Kauffman L., Singh R., Eglen RM: A generic, homogenous method for measuring kinase and inhibitor activity via adenosine 5′diphosphate accumulation. J Biomol Screen 2006 ; 11: 390-399.
14. Lochner A., Moolman JA: The many faces of H89: a review. Cardiovasc Drug Rev 2006 ; 24: 261-274.
15. Greis KD, Rathore R., Scott G., Vollmerhaus P., Corr J.: Multiplex enzyme inhibition screening via MALDI-3Q-MS [Poster TP155]. Paper presented at the 56th ASMS Conference on Mass Spectrometry & Allied Topics, Denver, Colorado, June 2008.